In July 2023 we attended a techUK webinar on fraud prevention in digital identity. Representatives of Synectics Solutions, Yoti and Mitek presented the “Shared Signals Pilot” (Project Shield): competing identity providers agreeing to exchange real-time alerts about compromised documents, credentials and identities. The panellists predicted that reusable digital identity would take off within three to five years, and that deepfakes would become the next major fraud vector.
Today KG Legal is taking part in a business meeting with a delegation from the Free State of Thuringia, led by Minister-President Mario Voigt, hosted at the National Synchrotron Radiation Centre SOLARIS in Kraków. The meeting is organised by the Polish-German Chamber of Industry and Commerce (AHK Polska) together with the Marshal’s Office of the Małopolska Region and the Business in Małopolska centre, with LEG Thüringen, the Thuringian economic development agency, as a partner.
Synthetic data, meaning text, images and tabular records produced by algorithms rather than collected from the real world, has moved from the research lab into everyday business use. It promises datasets that can be shared, tested and used to train AI without exposing real individuals. The law, however, does not accept that promise at face value. In 2026 the European Data Protection Board stated that synthetic data is not anonymous by default, the AI Act’s transparency duties for synthetic content began to apply, and Poland established its own AI supervisory authority. This article explains how synthetic data is generated and what legal conditions its generation and use must meet.
Clinical research, diagnostic testing and commercialisation under Polish and EU law
Law as at 5 November 2026
Abstract
A change in an epigenetic clock may justify further investigation of a medicine. Its value as evidence of benefit depends on what the clock measures, the population in which it has been validated and whether treatment effects on the score predict effects on health. The same assay may be used to analyse archived samples, select participants for treatment or sell a test to consumers. Each use raises a different legal question. This article traces those questions from trial design through to commercial use, with particular attention to Polish law on medical experiments, performance studies, access to medical records and the use of data from non-commercial clinical trials.
Keywords ageing biomarkers, geroprotectors, clinical trials, IVDR, biobanks, genetic data
From 11 November 2026, telecommunications undertakings in Poland must meet new technical and operational requirements for the interfaces that give law enforcement and security agencies access to communications and related data. Interfaces already running under existing agreements may stay on the previous standard, but for no longer than 36 months. The new rules add 5G standards, real-time delivery and a dedicated interface for retained data.